Bell Investment Advisors’s H&R Block HRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5K Buy
302
+70
+30% +$2.44K ﹤0.01% 666
2026
Q1
$7.36K Buy
232
+93
+67% +$3.24K ﹤0.01% 809
2025
Q4
$6.06K Sell
139
-8
-5% -$374 ﹤0.01% 899
2025
Q3
$7.43K Sell
147
-33
-18% -$1.74K ﹤0.01% 751
2025
Q2
$9.88K Hold
180
– – ﹤0.01% 679
2025
Q1
$9.88K Buy
180
+9
+5% +$481 ﹤0.01% 611
2024
Q4
$9.04K Sell
171
-7
-4% -$411 ﹤0.01% 644
2024
Q3
$11.3K Hold
178
– – ﹤0.01% 569
2024
Q2
$9.65K Buy
178
+1
+0.6% +$50 ﹤0.01% 625
2024
Q1
$8.69K Buy
177
+17
+11% +$808 ﹤0.01% 650
2023
Q4
$7.74K Buy
160
+6
+4% +$267 ﹤0.01% 657
2023
Q3
$6.63K Sell
154
-29
-16% -$1.07K ﹤0.01% 670
2023
Q2
$5.83K Buy
183
+38
+26% +$1.23K ﹤0.01% 738
2023
Q1
$5.11K Buy
145
+48
+49% +$1.77K ﹤0.01% 781
2022
Q4
$3.54K Sell
97
-11
-10% -$447 ﹤0.01% 987
2022
Q3
$5K Buy
108
+9
+9% +$381 ﹤0.01% 680
2022
Q2
$3K Buy
+99
New +$3.06K ﹤0.01% 952
2021
Q4
$0 Sell
21
-235
-92% -$5.7K ﹤0.01% 1858
2021
Q3
$6K Buy
+256
New +$6.38K ﹤0.01% 634

Other funds holding HRB

Bell Investment Advisors's HRB Position: Q2 2026 in Review

Bell Investment Advisors increased its H&R Block (HRB) stake by 30% in Q2 2026, buying an estimated $2.44K and bringing the position to 302 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #666.

Bell Investment Advisors first reported a position in HRB in Q3 2021 and has held it in 19 quarters since. 541 funds tracked by Wall St. Rank hold HRB as of Q2 2026.

  • Bell Investment Advisors held 302 shares of H&R Block worth $11.5K as of Q2 2026.
  • Bell Investment Advisors bought 70 H&R Block shares in Q2 2026, an estimated $2.44K.
  • H&R Block made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #666 holding.
  • Bell Investment Advisors first reported a position in H&R Block in Q3 2021 and has held it in 19 quarters since.
  • 541 funds tracked by Wall St. Rank held H&R Block as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.